Prognostic role of oestrogen, progesterone and androgen receptor in relation to patient age in patients with breast cancer

Breast

Volumn 5, Issue 3, 1996, Pages 123-126

  Collett, K ^a,b   Maehle B O ^a   Skjaerven R ^a   Aas, T ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030018130     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(96)90055-7     Document Type: Article

References (22)

1. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA 1991; 265: 391-395.
2. McGuire W L, Clark G M, Dressier L G, Owens M A. Role of steroid hormone receptors as prognostic factors in primary breast cancer. NCI Monogr 1986; 1: 19-23.
3. Clark G M, McGuire W L. Steroid receptors and other prognostic factors in primary breast cancer. Semin Oncol 1988; 15: 20-25.
4. Allegra J C, Lippman M E, Simon R et al. Association between steroid hormone receptor status and disease free interval in breast cancer. Cancer Treat Rep 1979; 63: 1271-1277.
5. Søreide J A, Lea O A, Varhaug J E, Skarstein A, Kvinnsland S. Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. Eur J Surg Oncol 1992; 18: 112-118.
6. Langer M, Kubista E, Schemper M, Spona J. Androgen receptors, serum androgen levels and survival of breast cancer patients. Arch Gynecol Obstet 1990; 247: 203-209.
7. Bryan R M, Mercer R J, Bennett R C, Rennie G C, Lie T H, Morgan F J. Androgen receptors in breast cancer. Cancer 1984; 54: 2436-2440.
8. Bryan R M, Mercer R J, Bennett R C, Rennie G C. Prognostic factors in breast cancer and the development of a prognostic index. Br J Surg 1986; 73: 267-271.
9. Schwarte M R. Carcino embryonic antigen and estrogen receptor. A prognostic duo in breast cancer? Cancer 1994; 74: 1519-1522.
10. Papatestas A E, Pertsemlidis D, Lesnick G, Miller S R, Fagerstrom R, Aufses A H. Association between prognosis and hormone receptors in women with breast cancer. Cancer Detect Prev 1986; 9: 303-310.
11. Shek L L, Godolphin W. Survival with breast cancer: the importance of estrogen receptor quantity. Eur J Clin Oncol 1989; 25: 243-250.
12. Thorsen T. Occupied and unoccupied nuclear oestradiol receptor in human breast tumours: relation to oestradiol and progesterone cytosol receptors. J Steroid Biochem 1979; 10: 661-668.
13. Lea O A, Kvinnsland S, Thorsen T. Improved measurement of androgen receptors in human breast cancer. Cancer Res 1989; 49: 7162-7167.
14. Simon R, Altman D G. Statistical aspects of prognostic factor studies in oncology. Br J Cancer 1994; 69: 979-985.
15. Dixon W J. BMDP Statistical Software Manual. University of California Press, 1990.
16. Molino A M, Turazza M, Bonetti A et al. Estrogen and progestrone receptors with correlation with clinical and pathological features and with prognosis. Oncology 1992; 49: 82-88.
17. Logan L A, Cripps M C, Hirte W E, Rapp E F. The estrogen receptor test: a prognostic tool in primary breast cancer. Can J Surg 1982; 25: 581-584.
18. Raemaekers JMM, Beex L V A M, Koenders A J M et al. Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up. Breast Cancer Res Treat 1985; 6: 123-130.
19. Pichon M F, Pallud C, Brunet M, Milgrom E. Relationship of presence of progesterone receptors to prognosis in early breast cancer. Cancer Res 1980; 40: 3357-3360.
20. Howat J M T, Harris M, Swindell R, Barnes D M. The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. Br J Cancer 1985; 51: 263-270.
21. Thorpe S M, Rose C. Oestrogen and progesterone receptor determinations in breast cancer: technology and biology. Cancer Surv 1986; 5: 505-525.
22. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339: 1-15, 71-85.